Michael Koch

机构：Friedrich-Alexander-Universität Erlangen-Nürnberg · ORCID：0000-0001-7838-6490

发表论文 311 篇 · 总被引 7941 次 · h-index 50

代表论文

• Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial (2023 · The Lancet Diabetes & Endocrinology · 被引 122)
• Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial (2023 · The Lancet Diabetes & Endocrinology · 被引 98)
• Risk stratification of thyroid nodules: Assessing the suitability of ChatGPT for text-based analysis (2023 · American Journal of Otolaryngology · 被引 34)
• Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study (2022 · Human Vaccines & Immunotherapeutics · 被引 33)
• Ultrasound in the diagnosis and differential diagnosis of enoral and plunging ranula: a detailed and comparative analysis (2022 · Journal of Ultrasound · 被引 10)
• Comparison of mucus and serum biomarker sampling in chronic rhinosinusitis with nasal polyps (2023 · International Forum of Allergy & Rhinology · 被引 9)